Initial Dose:

• 441 mg Aristada plus 21 days of oral aripiprazole
• 441 mg Aristada PLUS 30 mg of oral aripiprazole PLUS 675 mg Aristada Initio
• 960 mg Abilify Asimtufii plus 14 days or oral aripiprazole

Initial dose for patient already on Abilify Maintena:

• 960 mg Abilify Asimtufii; no oral overlap required

Maintenance Dose:

• 441 mg Aristada every 4 weeks
• 960 mg Abilify Asimtufii every two months

Initial Dose:

• 300 mg Abilify Maintena plus 14 days of oral aripiprazole
• 662 mg Aristada plus 21 days of oral aripiprazole
• 662 mg Aristada PLUS 30 mg oral aripiprazole PLUS 675 mg Aristada Initio
• 882 mg Aristada plus 21 days of oral aripiprazole
• 882 mg Aristada PLUS 30 mg oral aripiprazole PLUS 675 mg Aristada Initio
• 1064 mg Aristada plus 21 days of oral aripiprazole
• 1064 mg Aristada PLUS 30 mg oral aripiprazole PLUS 675 mg Aristada Initio

Maintenance Dose:

• 300 mg Abilify Maintena every 4 weeks
• 662 mg Aristada every 4 weeks
• 882 mg Aristada every 6 weeks
• 1064 mg Aristada every 8 weeks

Initial Dose:

• 400 mg Abilify Maintena plus 14 days of oral aripiprazole
• 882 mg Aristada plus 21 days of oral aripiprazole
• 882 mg Aristada PLUS 30 mg oral aripiprazole PLUS 675 Aristada Initio
• 960 mg Abilify Asimtufii plus 14 days of oral aripiprazole

Initial dose for patient already on Abilify Maintena:

• 960 mg Abilify Asimtufii; no oral overlap required

Maintenance Dose:

• 400 mg Abilify Maintena
• 882 mg Aristada every 4 weeks
• 960 mg Abilify Asimtufii every two months

• Suggested 6.25 mg fluphenazine decanoate every 2 weeks (or calculated at 1.25 mgx PO dose every 3-6 weeks)

• 12.5 mg (0.5 ml) fluphenazine decanoate every 3 weeks [can be given every 2 weeks]

• 25 mg (1 ml) fluphenazine decanoate every 3 weeks

• 37.5 mg (1.5 ml) fluphenazine decanoate every 3-6 weeks

• 50 mg (2 ml) fluphenazine decanoate every 3-6 weeks

• 10-15x PO dose haloperidol decanoate

• 10-15x PO dose haloperidol decanoate every 4 weeks

• 20x PO dose haloperidol decanoate

• 10-15x PO dose haloperidol decanoate every 4 weeks

Initial Dose:

• 234 mg Invega Sustenna on day 1 and 156 mg Invega Sustenna on day 8. Maintenance dose is given 5 weeks after first dose.

Maintenance Dose:

• 39 mg Invega Sustenna every 4 weeks

Initial Dose:

• 234 mg Invega Sustenna on day 1 and 156 mg Invega Sustenna on day 8. Maintenance dose is given 5 weeks after first dose.

Maintenance Dose:

• 78 mg Invega Sustenna every 4 weeks
• 273 mg Invega Trinza every 12 weeks (Stabilization with at least 4 months [4 injections] of Invega Sustenna required prior to initiation of Invega Trinza)

Initial Dose:

• 234 mg Invega Sustenna on day 1 and 156 mg Invega Sustenna on day 8. Maintenance dose is given 5 weeks after first dose.

Maintenance Dose:

• 117 mg Invega Sustenna every 4 weeks
• 410 mg Invega Trinza every 12 weeks (Stabilization with at least 4 months [4 injections] of Invega Sustenna required prior to initiation of Invega Trinza)

Initial Dose:

• 234 mg Invega Sustenna on day 1 and 156 mg Invega Sustenna on day 8. Maintenance dose is given 5 weeks after first dose.

Maintenance Dose:

• 156 mg Invega Sustenna every 4 weeks
• 546 mg Invega Trinza every 12 weeks (Stabilization with at least 4 months [4 injections] of Invega Sustenna required prior to initiation of Invega Trinza)
• 1,092 mg Invega Hafyera every 6 months (Stabilization with at least four months (4 injections) of Invega Sustenna or at least one three-month cycle (1 injection) of Invega Trinza prior to initiation of Invega Hafyera.)

Hint: Stabilization with at least four months (4 injections) of Invega Sustenna required prior to initiation of Invega Trinza.

Hint: Stabilization with at least four months (4 injections) of Invega Sustenna or at least one three-month cycle (1 injection) of Invega Trinza prior to initiation of Invega Hafyera.

Initial Dose:

• 234 mg Invega Sustenna on day 1 and 156 mg Invega Sustenna on day 8. Maintenance dose is given 5 weeks after first dose.

Maintenance Dose:

• 234 mg Invega Sustenna every 4 weeks
• 819 mg Invega Trinza every 12 weeks (Stabilization with at least 4 months [4 injections] of Invega Sustenna required prior to initiation of Invega Trinza)
• 1,560 mg Invega Hafyera every 6 months (Stabilization with at least four months (4 injections) of Invega Sustenna or at least one three month cycle (1 injection) of Invega Trinza prior to initiation of Invega Hafyera.)

Hint: Stabilization with at least four months (4 injections) of Invega Sustenna required prior to initiation of Invega Trinza.

Hint: Stabilization with at least four months (4 injections) of Invega Sustenna or at least one three-month cycle (1 injection) of Invega Trinza prior to initiation of Invega Hafyera.

• Risperdal Consta 12.5 mg every 2 weeks (+ 21 days oral risperidone overlap)
• Invega Sustenna 39 mg (no oral supplementation required)

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance, in patients with hepatic or renal impairment, or in patients who have a history of poor tolerability to psychotropic medications.

• Risperdal Consta 25 mg every 2 weeks (+ 21 days oral risperidone overlap)
• Uzedy 50 mg every month or 100 mg every 2 months
• Invega Sustenna 78 mg (no oral supplementation required)

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance, in patients with hepatic or renal impairment, or in patients who have a history of poor tolerability to psychotropic medications.

• Perseris 90 mg every 4 weeks
• Risperdal Consta 37.5 mg every 2 weeks (+ 21 days oral risperidone overlap)
• Uzedy 75 mg every month or 150 mg every 2 months
• Invega Sustenna 117 mg (no oral supplementation required)

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance, in patients with hepatic or renal impairment, or in patients who have a history of poor tolerability to psychotropic medications.

• Perseris 120 mg every 4 weeks
• Risperdal Consta 37.5-50 mg every 2 weeks (+21 days oral risperidone overlap)
• Uzedy 100 mg every month or 200 mg every 2 months
• Invega Sustenna 156 mg (no oral supplementation required)

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance, in patients with hepatic or renal impairment, or in patients who have a history of poor tolerability to psychotropic medications.

• Risperdal Consta 37.5-50 mg every 2 weeks (+21 days oral risperidone overlap)
• Uzedy 125 mg every month or 250 mg every 2 months
• Invega Sustenna 234 mg (no oral supplementation required)

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance, in patients with hepatic or renal impairment, or in patients who have a history of poor tolerability to psychotropic medications.

• Invega Sustenna 234 mg (no oral supplementation required)

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance, in patients with hepatic or renal impairment, or in patients who have a history of poor tolerability to psychotropic medications.

Initial 8 Weeks:

• 210 mg Zyprexa Relprevv every 2 weeks or 405 mg every 4 weeks

Maintenance Dose:

• 150 mg Zyprexa Relprevv every 2 weeks or 300 mg every 4 weeks

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance.

Initial 8 Weeks:

• 300 mg Zyprexa Relprevv every 2 weeks

Maintenance Dose:

• 210 mg Zyprexa Relprevv every 2 weeks or 405 mg every 4 weeks

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance.

Initial 8 Weeks:

• 300 mg Zyprexa Relprevv every 2 weeks

Maintenance Dose:

• 300 mg Zyprexa Relprevv every 2 weeks

Hint: Dose reduction may be necessary for CYP450 interactions of side effect intolerance.